Proteoglycan 4 or lubricin is a proteoglycan that in humans is encoded by the PRG4 gene.[3][4][5] This proteoglycan acts as a joint/boundary lubricant.[5]
Function
Lubricin is present in synovial fluid and on the surface (superficial layer) of articular cartilage and therefore plays an important role in joint lubrication and synovial homeostasis. When first isolated, cartilage lubricin was called "superficial zone protein" (SZP).[6][7] Lubricin, MSF, and SZP are now collectively known as Proteoglycan 4 (hence PRG4 for the gene nomenclature). The expression of lubricin has also been detected and the protein localized in tendon,[8] meniscus,[9] lung, liver, heart, bone,[10] ligament, muscle, and skin.[11]
Structure
The protein encoded by this gene is a proteoglycan of approximately 345 kDa[12] specifically synthesized by chondrocytes located at the surface of articular cartilage, and also by some synovial lining cells. The cDNA encodes a protein of 1,404 amino acids (human A isoform) with a somatomedin B homology domain, heparin-binding domains, multiple mucin-like repeats, a hemopexin domain, and an aggregation domain. There are 3 consensus sequences for N-glycosylation and 1 chondroitin sulfate substitution site.[5]
Lubricin is a large, water-soluble glycoprotein with a molecular weight of 206,000 Daltons and consists of approximately equal proportions of protein and oligosaccharides. Electron microscope measurements show that the lubricin molecule is a partially extended flexible rod and, in solution, occupies a smaller spatial domain than would be expected from structural predictions.[13] This characteristic may aid in the molecule's boundary lubricating ability.
Clinical significance
Lubricin, as MSF, was detected in the urine of patients undergoing bone marrow transplantation during a period of acute thrombocytopenia.[14] Depletion of lubricin function has also been associated with camptodactyly-arthropathy-coxa vara-pericarditis syndrome (CACP), an arthritis-like autosomal recessive disorder.[15]
The locus for autosomal recessive camptodactyly-arthropathy-coxa vara-pericarditis syndrome maps to chromosome 1q25-q31 where the PRG4 gene is located. Cell overgrowth may be primary to the pathogenesis of this protein.[5]
Lubricin’s role in improving tendon gliding has also been studied. While adding lubricin alone fails to affect the tendon gliding resistance, the addition of cd-gelatin plus lubricin significantly lowered the gliding resistance of the tendons. This research can aid in improving the gliding ability of tendon grafts done clinically.[16]
Extracorporeal shockwave therapy application has been shown to induce an increased lubricin expression in tendons and septa of rat hindlimbs, which might suggest a beneficial lubricanting effect for joints and tissues prone to wear and tear degradation. [17]
References
- 1 2 3 GRCh38: Ensembl release 89: ENSG00000116690 - Ensembl, May 2017
- ↑ "Human PubMed Reference:".
- ↑ Marcelino J, Carpten JD, Suwairi WM, Gutierrez OM, Schwartz S, Robbins C, Sood R, Makalowska I, Baxevanis A, Johnstone B, Laxer RM, Zemel L, Kim CA, Herd JK, Ihle J, Williams C, Johnson M, Raman V, Alonso LG, Brunoni D, Gerstein A, Papadopoulos N, Bahabri SA, Trent JM, Warman ML (Dec 1999). "CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome". Nat Genet. 23 (3): 319–22. PMID 10545950. doi:10.1038/15496.
- ↑ Flannery CR, Hughes CE, Schumacher BL, Tudor D, Aydelotte MB, Kuettner KE, Caterson B (Mar 1999). "Articular cartilage superficial zone protein (SZP) is homologous to megakaryocyte stimulating factor precursor and Is a multifunctional proteoglycan with potential growth-promoting, cytoprotective, and lubricating properties in cartilage metabolism". Biochem Biophys Res Commun. 254 (3): 535–41. PMID 9920774. doi:10.1006/bbrc.1998.0104.
- 1 2 3 4 "Entrez Gene: PRG4 proteoglycan 4".
- ↑ Schumacher BL, Block JA, Schmid TM, Aydelotte MB, Kuettner KE (1994). "A novel proteoglycan synthesized and secreted by chondrocytes of the superficial zone of articular cartilage.". Arch Biochem Biophys. 311 (1): 144–52. PMID 8185311. doi:10.1006/abbi.1994.1219.
- ↑ Jay GD, et al. (2000). "Lubricin is a product of megakaryocyte stimulating factor gene expression by human synovial fibroblasts.". J Rheumatol. 27 (3): 594–600. PMID 10743795.
- ↑ Rees; Davies, JR; Tudor, D; Flannery, CR; Hughes, CE; Dent, CM; Caterson, B; et al. (2002). "Immunolocalisation and expression of proteoglycan 4 (cartilage superficial zone proteoglycan) in tendon". Matrix Biol. 21 (7): 593–602. PMID 12475643. doi:10.1016/S0945-053X(02)00056-2.
- ↑ Schumacher BL, et al. (2005). "Proteoglycan 4 (PRG4) synthesis and immunolocalization in bovine meniscus.". J Orthop Res. 23 (3): 562–568. PMID 15885476. doi:10.1016/j.orthres.2004.11.011. .
- ↑ Ikegawa S, et al. (2000). "Isolation, characterization and mapping of the mouse and human PRG4 (proteoglycan 4) genes.". Cytogenet Cell Genet. 90 (3-4): 291–297. PMID 11124536. doi:10.1159/000056791.
- ↑ Sun Y, et al. (2006). "Mapping lubricin in canine musculoskeletal tissues.". Connect Tissue Res. 47 (4): 215–221. PMID 16987753. doi:10.1080/03008200600846754. .
- ↑ Su JL, Schumacher BL, Lindley KM, et al. (June 2001). "Detection of superficial zone protein in human and animal body fluids by cross-species monoclonal antibodies specific to superficial zone protein". Hybridoma. 20 (3): 149–57. PMID 11461663. doi:10.1089/027245701750293475.
- ↑ Swann DA, et al. (1981). "The molecular structure of lubricating glycoprotein-I, the boundary lubricant for articular cartilage.". J Biol Chem. 256 (11): 5921–5925. PMID 7240180.
- ↑ Merberg DM et al. (1993) Comparison of vitronectin and megakaryocyte stimulating factor. In Biology of Vitronectins and their Receptors. (Preissner et al., eds) pp45-52 (Elsevier Science, Amsterdam).
- ↑ Marcelino J, et al. (1999). "CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome.". Nat Genet. 23 (3): 319–322. PMID 10545950. doi:10.1038/15496. .
- ↑ Taguchi M, Jay GD, et al. (Jan 2008). "Lubricin Surface Modification Improves Extrasynovial Tendon Gliding in a Canine Model in Vitro". The Journal of Bone and Joint Surgery. 90 (1): 129–135. PMID 18171967. doi:10.2106/JBJS.G.00045.
- ↑ Zhang D, Kearney CJ et al. (Jan 2011). "Extracorporeal shockwave-induced expression of lubricin in tendons and septa". Cell and Tissue Research. 346 (2): 255–263. PMID 22009294. doi:10.1007/s00441-011-1258-7.
Further reading
- Schumacher BL, Block JA, Schmid TM, et al. (1994). "A novel proteoglycan synthesized and secreted by chondrocytes of the superficial zone of articular cartilage.". Arch. Biochem. Biophys. 311 (1): 144–52. PMID 8185311. doi:10.1006/abbi.1994.1219.
- Bahabri SA, Suwairi WM, Laxer RM, et al. (1998). "The camptodactyly-arthropathy-coxa vara-pericarditis syndrome: clinical features and genetic mapping to human chromosome 1.". Arthritis Rheum. 41 (4): 730–5. PMID 9550484. doi:10.1002/1529-0131(199804)41:4<730::AID-ART22>3.0.CO;2-Y.
- Jay GD, Britt DE, Cha CJ (2000). "Lubricin is a product of megakaryocyte stimulating factor gene expression by human synovial fibroblasts.". J. Rheumatol. 27 (3): 594–600. PMID 10743795.
- Ikegawa S, Sano M, Koshizuka Y, Nakamura Y (2001). "Isolation, characterization and mapping of the mouse and human PRG4 (proteoglycan 4) genes.". Cytogenet. Cell Genet. 90 (3-4): 291–7. PMID 11124536. doi:10.1159/000056791.
- Rees SG, Davies JR, Tudor D, et al. (2003). "Immunolocalisation and expression of proteoglycan 4 (cartilage superficial zone proteoglycan) in tendon.". Matrix Biol. 21 (7): 593–602. PMID 12475643. doi:10.1016/S0945-053X(02)00056-2.
- Morawietz L, Gehrke T, Frommelt L, et al. (2003). "Differential gene expression in the periprosthetic membrane: lubricin as a new possible pathogenetic factor in prosthesis loosening.". Virchows Arch. 443 (1): 57–66. PMID 12783322. doi:10.1007/s00428-003-0818-y.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40–5. PMID 14702039. doi:10.1038/ng1285.
- Liu YJ, Lu SH, Xu B, et al. (2004). "Hemangiopoietin, a novel human growth factor for the primitive cells of both hematopoietic and endothelial cell lineages.". Blood. 103 (12): 4449–56. PMID 14976050. doi:10.1182/blood-2003-06-1825.
- Beausoleil SA, Jedrychowski M, Schwartz D, et al. (2004). "Large-scale characterization of HeLa cell nuclear phosphoproteins.". Proc. Natl. Acad. Sci. U.S.A. 101 (33): 12130–5. PMC 514446 . PMID 15302935. doi:10.1073/pnas.0404720101.
- de Haan G (2006). "A novel growth factor encoded by an old gene.". Haematologica. 90 (2): 152. PMID 15710563.
- Rhee DK, Marcelino J, Al-Mayouf S, et al. (2005). "Consequences of disease-causing mutations on lubricin protein synthesis, secretion, and post-translational processing.". J. Biol. Chem. 280 (35): 31325–32. PMID 16000300. doi:10.1074/jbc.M505401200.
- Liu T, Qian WJ, Gritsenko MA, et al. (2006). "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.". J. Proteome Res. 4 (6): 2070–80. PMC 1850943 . PMID 16335952. doi:10.1021/pr0502065.
- Alazami AM, Al-Mayouf SM, Wyngaard CA, Meyer B (2006). "Novel PRG4 mutations underlie CACP in Saudi families.". Hum. Mutat. 27 (2): 213. PMID 16429407. doi:10.1002/humu.9399.
- Gregory SG, Barlow KF, McLay KE, et al. (2006). "The DNA sequence and biological annotation of human chromosome 1.". Nature. 441 (7091): 315–21. PMID 16710414. doi:10.1038/nature04727.
- Zhang D, Johnson LJ, Hsu HP, Spector M (2007). "Cartilaginous deposits in subchondral bone in regions of exposed bone in osteoarthritis of the human knee: histomorphometric study of PRG4 distribution in osteoarthritic cartilage.". J. Orthop. Res. 25 (7): 873–83. PMID 17343281. doi:10.1002/jor.20344.
- Jay GD, Torres JR, Warman ML, et al. (2007). "The role of lubricin in the mechanical behavior of synovial fluid.". Proc. Natl. Acad. Sci. U.S.A. 104 (15): 6194–9. PMC 1851076 . PMID 17404241. doi:10.1073/pnas.0608558104.
External links
|
---|
Angiopoietin |
- Kinase inhibitors: Altiratinib
- CE-245677
- Rebastinib
|
---|
CNTF | |
---|
EGF (ErbB) | |
---|
FGF | FGFR1 | |
---|
FGFR2 |
- Agonists: Ersofermin
- FGF (1, 2 (bFGF), 3, 4, 5, 6, 7 (KGF), 8, 9, 10 (KGF2), 17, 18, 22)
- Palifermin
- Repifermin
- Sprifermin
- Trafermin
- Antibodies: Aprutumab
- Aprutumab ixadotin
|
---|
FGFR3 | |
---|
FGFR4 | |
---|
Unsorted | |
---|
|
---|
HGF (c-Met) | |
---|
IGF | IGF-1 |
- Kinase inhibitors: BMS-754807
- Linsitinib
- NVP-ADW742
- NVP-AEW541
- OSl-906
|
---|
IGF-2 |
- Antibodies: Dusigitumab
- Xentuzumab (against IGF-1 and IGF-2)
|
---|
Others |
- Cleavage products/derivatives with unknown target: Glypromate (GPE, (1-3)IGF-1)
- Trofinetide
|
---|
|
---|
LNGF (p75NTR) |
- Aptamers: Against NGF: RBM-004
- Decoy receptors: LEVI-04 (p75NTR-Fc)
|
---|
PDGF | |
---|
RET (GFL) | |
---|
SCF (c-Kit) | |
---|
TGFβ | |
---|
Trk | TrkA |
- Negative allosteric modulators: VM-902A
- Aptamers: Against NGF: RBM-004
- Decoy receptors: ReN-1820 (TrkAd5)
|
---|
TrkB |
- Agonists: 3,7-DHF
- 3,7,8,2'-THF
- 4'-DMA-7,8-DHF
- 7,3'-DHF
- 7,8-DHF
- 7,8,2'-THF
- 7,8,3'-THF
- Amitriptyline
- BDNF
- BNN-20
- Deoxygedunin
- Diosmetin
- GZ-389988
- HIOC
- LM22A-4
- N-Acetylserotonin
- NT-3
- NT-4
- Norwogonin (5,7,8-THF)
- R7
- TDP6
|
---|
TrkC | |
---|
|
---|
VEGF | |
---|
Others |
- Additional growth factors: Adrenomedullin
- Colony-stimulating factors (see here instead)
- Connective tissue growth factor (CTGF)
- Ephrins (A1, A2, A3, A4, A5, B1, B2, B3)
- Erythropoietin (see here instead)
- Glucose-6-phosphate isomerase (GPI; PGI, PHI, AMF)
- Glia maturation factor (GMF)
- Hepatoma-derived growth factor (HDGF)
- Interleukins/T-cell growth factors (see here instead)
- Leukemia inhibitory factor (LIF)
- Macrophage-stimulating protein (MSP; HLP, HGFLP)
- Midkine (NEGF2)
- Migration-stimulating factor (MSF; PRG4)
- Oncomodulin
- Pituitary adenylate cyclase-activating peptide (PACAP)
- Pleiotrophin
- Renalase
- Thrombopoietin (see here instead)
- Wnt signaling proteins
- Additional growth factor receptor modulators: Cerebrolysin (neurotrophin mixture)
|
---|
- See also
- Receptor/signaling modulators
- Signaling peptide/protein receptor modulators
- Cytokine receptor modulators
|